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Abstract: Regional adiposity is classically related with inflammation, insulin resistance (IR) and an
altered blood lipid profile. Traditionally, central adiposity expressed as a ratio (%FM) = fat
mass/total mass of the region is the variable most used in research. However, this ratio does
not account for total bodily fat mass (TFM). So, a great accumulation in a region, where lean
mass is more important than fat, could be more associated with risk factors than other with less
absolute fat (kg) but higher percentage (in instance abdomen). PURPOSE: To analyse the
associations between the ratio (RW) = regional fat mass (kg) / TFM (kg) and blood lipid
profile, IR and inflammation.
METHODS: Sixty-two pre-menopausal and healthy women were recruited for this study (age,
39.6 ±7.2 years; BMI, 29.2 ±4.2 kg.m-2; total %TFM, 42.0 ±5.9%). Weight and height were
measured to the nearest 0.1 kg and 0.1 cm respectively, and body composition was estimated
with dual energy x-ray aborptiometry. RWF were calculated for trunk (RWT), lower limbs
(RWLL) and upper limbs (RWUL). Insulin, glycaemia and insulin sensitivity (HOMA) were
the IR markers. C-reactive protein (CRP) and Tumour Necrosis Factor (TNF-α) were the
inflammation variables. Total cholesterol (TC), low-density lipoprotein (LDL), high-density
lipoprotein (HDL) and triglycerides (TG) were also measured. Partial correlations adjusted to
TFM between RW and blood markers were carried out.
RESULTS: Significant correlations were found between RWUL and HOMA (r=0.276,
P<0.05), TG (r=0.292, P<0.05) and insulin (r=0.271, P<0.05). RWT was also correlated with
blood lipids: TG (r=0.278, P<0.05) and LDL (r=-0.318, P<0.05). Finally, RWLL was the ratio
with more number of associations: HOMA (r=-0.274, P<0.05), TG (r=-0.342, P<0.01), LDL
(r=0.317, P<0.05) and insulin (r=-0.253, P<0.05). Abdominal and trunk %FM were only
correlated with HOMA (r=0.380, P<0.01) and LDL (r=0.264, P<0.05) respectively.
CONCLUSION: In our sample, regional fat mass contribution (RW) for whole body FM
showed more associations with blood markers than classical ratios (regional %FM). These
findings highlighted RW ratios were well correlated with inflammatory and IR risk factors,
which in turn could be useful to express positive or negative results in future studies. This
issue requires further investigation.
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